Oncogenes and cell death - PubMed

Review

Oncogenes and cell death

E A Harrington et al. Curr Opin Genet Dev. 1994 Feb.

Abstract

Several recent studies have implicated oncogenes and tumour suppressor genes in the regulation of programmed cell death (apoptosis). Lesions in the cell death pathway appear to be important in both carcinogenesis and the evolution of drug resistance in tumours. They include deregulated expression of genes such as bcl-2, loss of p53, and autocrine activation of anti-apoptotic signal transduction pathways. Paradoxically, a number of dominant oncogenes appear to act as potent inducers of apoptosis. This suggests that the pathways of cell proliferation and cell death may be tightly coupled, an idea that may have dramatic implications for models of oncogene co-operation and carcinogenesis.

Similar articles

• Review article: The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation.

  Sugerman PB, Joseph BK, Savage NW. Sugerman PB, et al. Oral Dis. 1995 Sep;1(3):172-88. doi: 10.1111/j.1601-0825.1995.tb00181.x. Oral Dis. 1995. PMID: 8705824 Review.

• Dominant oncogenes, tumor suppressors, and radiosensitivity.

  Chiarugi V, Magnelli L, Cinelli M, Turchetti A, Ruggiero M. Chiarugi V, et al. Cell Mol Biol Res. 1995;41(3):161-6. Cell Mol Biol Res. 1995. PMID: 8589756 Review.

• [Molecular biology of cell death].

  Tsujimoto Y. Tsujimoto Y. Gan To Kagaku Ryoho. 1994 Apr;21(5):591-5. Gan To Kagaku Ryoho. 1994. PMID: 8154883 Review. Japanese.

• Cell death regulation during multistep lymphomagenesis.

  Hsu B, Marin MC, McDonnell TJ. Hsu B, et al. Cancer Lett. 1995 Jul 20;94(1):17-23. doi: 10.1016/0304-3835(95)03836-l. Cancer Lett. 1995. PMID: 7621440

• The genetics of programmed (apoptotic) cell death.

  Lin X, Denmeade SR, Isaacs JT. Lin X, et al. Cancer Surv. 1995;25:173-94. Cancer Surv. 1995. PMID: 8718518 Review.

Cited by

• Apoptosis and its control in cell culture systems.

  Singh RP, Finka G, Emery AN, Al-Rubeai M. Singh RP, et al. Cytotechnology. 1997 Jan;23(1-3):87-93. doi: 10.1023/A:1007971703392. Cytotechnology. 1997. PMID: 22358524 Free PMC article.

• Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts.

  Felsher DW, Zetterberg A, Zhu J, Tlsty T, Bishop JM. Felsher DW, et al. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10544-8. doi: 10.1073/pnas.190327097. Proc Natl Acad Sci U S A. 2000. PMID: 10962037 Free PMC article.

• Antiangiogenis restricted tumor dormancy.

  Holmgren L. Holmgren L. Cancer Metastasis Rev. 1996 Jun;15(2):241-5. doi: 10.1007/BF00437478. Cancer Metastasis Rev. 1996. PMID: 8842497 Review. No abstract available.

• Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of Fas.

  Yin F, Shi YQ, Zhao WP, Xiao B, Miao JY, Fan DM. Yin F, et al. World J Gastroenterol. 2000 Oct;6(5):664-670. doi: 10.3748/wjg.v6.i5.664. World J Gastroenterol. 2000. PMID: 11819671 Free PMC article.

• Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER⁺/HER2^- Breast Cancer.

  Dowsett M, Kilburn L, Rimawi MF, Osborne CK, Pogue-Geile K, Liu Y, Jacobs SA, Finnigan M, Puhalla S, Dodson A, Martins V, Cheang M, Perry S, Holcombe C, Turner N, Swift C, Bliss JM, Johnston S; PALLET trialists. Dowsett M, et al. Clin Cancer Res. 2022 Jan 1;28(1):163-174. doi: 10.1158/1078-0432.CCR-21-1628. Epub 2021 Oct 13. Clin Cancer Res. 2022. PMID: 34645649 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal